Connect with us

Hi, what are you looking for?

News

U.S. FDA Now Allows Pharmacies To Sell Abortion Pill

Abortion pill
U.S. FDA now allows certain pharmacies to sell abortion pills. (Photo: ABC News)

The U.S. Food and Drug Administration (FDA) updated its website and said that it now allows certain pharmacies to sell the prescribed abortion pill.

Abortion pill

U.S. FDA now allows certain pharmacies to sell abortion pills. (Photo: ABC News)

U.S. FDA Allows Pharmacies To Sell Abortion Pill

Retail pharmacies can now start to sell mifepristone as long as the pharmacies meet the requirements and it is prescribed by a healthcare provider. This is the latest update posted on the website of the U.S. Food and Drug Administration.

However, this is only allowed in states where the selling of abortion pills is already legal. Likewise, healthcare providers or doctors might also be willing to get certified to prescribe the abortion pill rather than stock it themselves and write other prescriptions.

However, this opens other legal battles and challenges, especially for the different rights advocates and groups. According to these groups, only the FDA and not the state officials can decide which medication is safe enough to be sold in pharmacies.

READ ALSO: Notorious Mexican Drug Cartel Leader, FBI’s Ten Most Wanted Fugitives Is Busted Out Of Prison

Drug Providers Released a Statement

Danco Laboratories, which produces the drug under the brand name Mifeprex, said in a statement, “At a time when people across the country are struggling to obtain abortion care services this modification is critically important to expanding access to medication abortion services and will provide healthcare providers with an additional method for providing their patients with a safe and effective option for ending early pregnancy.”

Likewise, Evan Masingill, CEO of GenBioPro, which manufactures the generic version of the abortion pill, said that FDA’s action is a step in the right direction and will increase access and it will minimize the burden on the healthcare systems.

Masingill added, “Despite the FDA’s expert judgment, some states have restricted access to medical abortion care, so unfortunately today’s announcement will not provide equal access to all people. GenBioPro looks forward to working with prescribers and pharmacies to increase access to medical abortion care for all people.”

 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *